An in silico analysis of RNA sequencing data revealed an increased expression of CD8+ T-cells as well as M2 macrophages in advanced rectal cancer in response to neoadjuvant RCT with 25 × 1.8 or 2 Gy in addition to different chemotherapeutic agents [26]. Here, CD8A is linked to rectal cancer.